Company profile: Dow Pharmaceutical Sciences
1.1 - Company Overview
Company description
- Provider of topical drug product development services for pharmaceutical and biotechnology clients.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Dow Pharmaceutical Sciences
CellASIC
HQ: United States
Website
- Description: Provider of microfluidic platforms for live cell analysis, enabling long-term perfusion cell culture and dynamic flow control. The biotechnology company develops cutting-edge microfluidics technology to support superior live cell experiments.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CellASIC company profile →
HiFiBiO Therapeutics
HQ: France
Website
- Description: Provider of proprietary single-cell technologies for drug and biomarker discovery and development, and biotherapeutic antibody candidates that mobilize the immune system, including targets TNFR2, OX-40, BTLA, Gal-9, CCR8, and CXCR5 for solid tumors, myeloid malignancies, B cell lymphomas, and autoimmune diseases; collaborates through open-innovation partnerships with industry and academia.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full HiFiBiO Therapeutics company profile →
GenVault
HQ: United States
Website
- Description: Provider of sample management solutions for disease diagnosis, research, identification and criminal investigations, offering secure, GxP-compliant biorepository storage for over 60,000,000 samples (ambient to cryogenic), specialized transport and lab relocation with full chain-of-custody and GxP/USDOT compliance, and end-to-end bioinventory support—accession, monitoring, tracking, reporting and disposal—via a secure online portal.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full GenVault company profile →
Remynd
HQ: Belgium
Website
- Description: Provider of investigational programs for CNS protein misfolding disorders, including ReS19-T for Alzheimer’s, ReS18-H for Huntington’s, and ReS3-T for Alzheimer’s and epilepsy, plus a CRO that assesses pharmacokinetics, pharmacodynamics, and efficacy in proprietary animal models, and a phenotypic screening platform to discover small-molecule treatments and novel targets.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Remynd company profile →
Ahura Scientific
HQ: United States
Website
- Description: Provider of rugged, ultra-compact, field-enabled optical systems for the immediate identification and authentication of liquid and solid chemical substances, serving homeland security, life sciences, industrial, and medical markets; products include handheld XRF and LIBS analyzers, portable narcotics and chemical identifiers, manufactured in the USA in an ISO 9001-certified facility.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ahura Scientific company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Dow Pharmaceutical Sciences
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Dow Pharmaceutical Sciences
2.2 - Growth funds investing in similar companies to Dow Pharmaceutical Sciences
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Dow Pharmaceutical Sciences
4.2 - Public trading comparable groups for Dow Pharmaceutical Sciences
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →